COVID-19 Saliva Sampling Test Market Reveals Promising Growth USD 5.4 Billion at a 5.1% of CAGR

COVID-19 Saliva Sampling Test Market

A newly released market analysis report by Future Market Insights indicates that the global COVID-19 saliva sampling test market generated sales of approximately USD 3.1 billion in 2021. With a projected compound annual growth rate (CAGR) of 5.1% from 2022 to 2032, the market growth is anticipated to significantly outpace historical growth rates.

The report highlights that the fluorescence-labeled antigen/antibody testing segment is expected to be the leading revenue generator within the market. This segment is projected to experience robust growth, with a CAGR exceeding 5.1% over the forecast period.

The increasing demand for non-invasive testing methods, along with the growing preference for saliva sampling in both clinical and home settings, is driving the market’s expansion. Saliva-based tests are recognized for their ease of use, rapid results, and patient comfort, making them a preferred choice for COVID-19 testing.

As the cases of people visiting public places grow, visitors have begun to predominate in some locations worldwide, leading to an increase in demand for testing at point-of-care to determine whether a person is contagious with the coronavirus disease (COVID-19). This has fuelled technological innovation, which is spurring improvements in the sequencing of saliva-based diagnostic tests to prevent viral transmission from asymptomatic individuals.

Fluorescence-labelled antigen/antibody testing allows for the rapid identification of contagious individuals and is an effective Sampling modality for cruise ships, aeroplanes, sports stadiums, and schools. The combination of vaccination and rapid and frequent testing with fluorescence-labelled antigen/antibodies tests has the potential to end the pandemic. The system for fluorescence-labelled antigen/antibody testing is intended to accelerate rapid point-of-access testing of individuals by utilizing the principles of fluorescence detection, biochemistry, robotics automation, and cloud computing.

Owing to the physiological changes associated with ageing and potential underlying health conditions, the ageing population is at a high risk of developing severe illness. Poor health status, decreased organ function, weakened immune function, an increased likelihood of multiple underlying diseases, and a lack of attention to personal health can all increase susceptibility to various diseases in the elderly. As a result, the growing population of people over the age of 65 indicates that a greater proportion of people in this age group are at risk of contracting the disease. As a result, the ageing population is more vulnerable to viral infections, which will increase demand for COVID-19 saliva-based Sampling.

Competitive Landscape

Market players are actively working on innovative solutions and expanding their product portfolios to gain a competitive edge. To assist healthcare organizations in implementing data analysis solutions, address the challenges posed by the COVID-19 pandemic, and maintain market competitiveness, companies are focusing on partnerships, technology collaborations, and product launch strategies.

Here are some recent advancements from key providers in the COVID-19 saliva sampling test market:

• In April 2021, Chembio Diagnostics, Inc. introduced a rapid point-of-care test (POCT) designed for use in both decentralized and traditional diagnostic settings, addressing the demand for COVID-19 testing. The product was made available promptly to customers across the United States.
• In the same month, Vatic Health received the CE mark for its on-the-spot SARS-CoV-2 saliva antigen test, which is also registered with the Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom.
• In March 2020, Abbott launched ID NOW, a molecular point-of-care test for detecting COVID-19, after obtaining Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration. The device is compact, lightweight (6.6 pounds), and portable, producing positive results in as little as five minutes and negative results in about 13 minutes.

Additionally, the Future Market Insights team has been tracking recent developments related to companies providing COVID-19 saliva sampling test services, which are detailed in the comprehensive report.

Market Segments Covered in COVID-19 Saliva Sampling Test Potential Market Analysis

By Location:

• Travel Stations
• Sports Arenas
• Entertainment Venues
• Corporate Campus Environments
• Universities & Colleges
• Factories

By Technology:

• Fluorescence-labeled antigen/antibodies testing
• RT-PCR
• CRISPR-Cas9

By Mode:

• Centralized Testing
• Decentralized Testing

By Region:

• North America
• Latin America
• Europe
• APAC
• MEA

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube